Eli Lilly announces the complete phase III data of new drugs for Alzheimer's disease, which may compete with Eisai at the end of the year
TRAILBLAZER-ALZ2 Design of experiments and summary of results. Image source: Journal of the American Medical AssociationOn July 17 local time, the United States Lilly (LLY...
SpaceX expects to double its revenue to $8 billion in 2023
[Global Network Technology Comprehensive Report] On July 18, according to The Information, insiders said that SpaceX, a Space exploration technology company owned by Elon Musk, disclosed to some investors that it is expected that the company will achieve revenue of about 8 billion dollars (about 57.3 billion yuan at present) in 2023, about twice the revenue of the previous year...